Assessment of quality and consistency of monoclonal antibodies for CB1 and CB2 in head and neck squamous cell carcinoma.

Kelly E DanielsAdam J LuginbuhlStacey K MardekianDavid M CognettiJoseph M CurryAndrew P South

Published in: Head & neck (2019)

Interpretation of CB1/CB2 antibody data should be performed cautiously and confirmation of findings across multiple experimental methods is recommended.

Keyphrases

electronic health record
big data
artificial intelligence